10/14/2026
Exciting news in retinal research! 👁️
Merck recently shared results from a clinical trial studying remigromig, a potential new treatment for diabetic macular edema (DME), an eye condition that can affect vision in people with diabetes.
Southwest Retina Specialists has a special connection to this research! During an earlier study, Dr. Eddie Ysasaga gave the first-ever human injection of remigromig.
While remigromig is still being studied and is not yet approved for clinical use, these latest findings mark an important step in its ongoing evaluation.
Swipe through to learn more about the research and Southwest Retina Specialists' role in it!
🔗 Read more from Merck: https://ow.ly/1j4W50ZXJN5